Objectives

Mast Cell Activation Disease

Current Concepts

Identifying and treating Mast Cell Activation Disease for patients with Ehlers-Danlos Syndromes

The participant will increase their knowledge and understand basic aspects of the realm of allergic diseases and mastocytosis.  In this webinar,  the new nosology of mast cell disease, principally the key distinctions between mastocytosis and mast cell activation syndrome will be discussed.

The presentation will focus on the typical clinical presentation of mast cell activation syndrome and the basic principles of treating the syndrome. The program will enable the participant to better understand these  conditions and apply appropriate techniques in their practice.

Learning objectives

After watching this webinar the participant will be better able to:

  • Understand basic aspects of the realm of allergic diseases and mastocytosis.
  • Understand the new nosology of mast cell disease, principally the key distinctions between mastocytosis and mast cell activation syndrome.
  • Understand the typical clinical presentation of mast cell activation syndrome and the basic principles of treating the syndrome.

Speaker:

Lawrence B. Afrin, M.D.

(Armonk Integrative Medicine Armonk, NY)  

Completion requirement

Participants must complete and submit the evaluation for the activity in order to receive  a credit letter.  Participants must also pass a post-test activity with 80% or higher  to receive this credit letter.

Credit letters can be printed or downloaded from this site and upon request  can be issued via email.